Core Viewpoint - The article highlights three high-yield dividend stocks with an average yield of 8.63%, presenting them as attractive investment opportunities for income-seeking investors. Group 1: Dividend Stocks Performance - Public companies that regularly pay dividends are typically profitable and capable of long-term growth, supported by historical data [2] - A study by Hartford Funds and Ned Davis Research shows that dividend-paying stocks outperformed non-payers by 9.2% annually over a 51-year period [4] Group 2: Investment Opportunities - Pfizer offers a yield of 7.46%, with sustainable earnings despite concerns over tariff impacts and a decline in COVID-19 therapy sales [7][9] - Verizon Communications has a yield of 6.39%, significantly higher than the S&P 500 average, and is positioned to benefit from the 5G expansion despite facing growth challenges [13][16] - PennantPark Floating Rate Capital boasts a yield of 12.04%, focusing on debt investments in middle-market companies, benefiting from higher market-rate yields due to its variable-rate debt portfolio [20][22] Group 3: Financial Metrics and Growth - Pfizer's revenue increased from $41.9 billion in 2020 to $63.6 billion in 2024, marking a 52% growth [9] - Verizon's broadband connections grew by 13.7% year-over-year, reaching 12.6 million [17] - PennantPark's weighted average yield on debt investments is 10.6%, with a significant portion of its debt securities being first-lien secured [22][23]

Core Insights - The article highlights the performance of dividend-paying stocks during market downturns, emphasizing their stability and ability to outperform the S&P 500 in 2025 [1][2] Group 1: AT&T - AT&T is a major U.S. telecom provider with 72.7 million post-paid phone subscribers and 9.3 million fiber optic broadband customers as of the end of 2024 [3] - The stock has a low beta of 0.42, indicating less volatility during market downturns, and offers a dividend yield of 4.1%, which is sustainable as it represents only half of the company's earnings-per-share estimate for 2025 [4] Group 2: Philip Morris International - Philip Morris is the largest tobacco company globally, selling products in 180 countries, and has a beta of 0.44, making it a reliable investment during economic downturns [5] - The company has consistently paid and raised its dividend since 2008, currently yielding 3.2%, and smoke-free products now account for 40% of total sales, indicating a shift towards long-term growth [6] Group 3: The Coca-Cola Company - Coca-Cola is a well-established blue-chip dividend stock with a diverse portfolio of beverages and a low beta of 0.45, making it a stable investment choice [7][8] - The company has a dividend yield of 2.8% and a payout ratio of 69% of 2025 earnings estimates, with a strong track record of increasing dividends over six decades [9]

Core Viewpoint - American Express is highlighted as a strong dividend stock, offering sustainable income through dividend growth, especially during market volatility [1][2]. Group 1: Company Overview - American Express was founded in 1850 and has evolved significantly since launching its credit card line in 1958, becoming one of the largest credit card issuers in the U.S. and globally [3]. - As of the end of Q1, American Express had approximately 147.5 million credit cards in circulation, adding 3.4 million net new cards in the quarter, indicating potential future earnings growth [4]. Group 2: Customer Demographics - Millennials and Gen Z are increasingly drawn to American Express credit cards, accounting for 35% of spending last quarter, with a year-over-year growth of 14%, representing the future customer base for the company [5]. Group 3: Financial Metrics - American Express maintains strong credit metrics, with a net write-off rate of 2.1%, significantly lower than the 5% rate of competitor Discover Financial, suggesting resilience during economic downturns [6]. - Over half of American Express' revenue comes from swipe fees, with an additional 14% from annual fees, contributing to more stable earnings compared to traditional banks [7]. Group 4: Dividend Growth - The company has experienced a 152% growth in earnings per share (EPS) over the last decade, alongside a cumulative 120% increase in dividend per share, with a recent 17% hike in the quarterly dividend [9]. - The current dividend yield stands at 1.09%, with expectations for growth based on the cost basis for new investors [9]. Group 5: Share Buyback Program - American Express has reduced its shares outstanding by 30% over the last 10 years through a share buyback program, enhancing the ownership stake of existing shareholders [10]. - This reduction in shares outstanding facilitates easier growth in dividend payouts, making American Express an attractive option for long-term investors [11].

Core Viewpoint - The current economic environment presents a favorable opportunity for investors to consider solid dividend stocks, which tend to be more resilient than non-dividend-paying companies amid market volatility and potential recession [1]. Group 1: Dividend Stocks Overview - Four recommended dividend-paying stocks during the current market sell-off are AbbVie, Amgen, Bristol Myers Squibb, and Zoetis [2]. Group 2: AbbVie - AbbVie is recognized for its strong position in immunology, despite facing challenges such as a patent cliff and clinical setbacks [3]. - The company has increased its 2027 revenue guidance for key products Skyrizi and Rinvoq by $4 billion to over $31 billion, indicating strong growth potential [4]. - AbbVie has a robust pipeline and a history of increasing dividends for 53 consecutive years, with a forward yield of 3.9%, significantly above the S&P 500 average of 1.3% [5]. Group 3: Amgen - Amgen's shares faced a decline due to underperformance of its weight loss candidate, MariTide, but the company has a strong portfolio with over 10 blockbuster drugs [6]. - Key growth drivers include asthma medicine Tezspire and FDA-approved Tepezza for thyroid eye disease, supporting a strong revenue outlook [7]. - Since initiating dividends in 2011, Amgen has increased payouts by 750%, with a forward yield exceeding 3.5% [8]. Group 4: Bristol Myers Squibb - Bristol Myers is facing significant patent cliffs, particularly for its best-sellers Opdivo and Eliquis, but has managed to secure new approvals to mitigate revenue loss [9]. - Newer medicines like Reblozyl and Opdualag are expected to drive future sales growth [10]. - The company has increased its dividend by nearly 68% over the past decade, offering a yield of 5.1% [11]. Group 5: Zoetis - Zoetis, a leader in animal health, started the year with disappointing guidance but has a strong portfolio with 15 products generating over $100 million in annual sales [12]. - The company is expected to overcome current challenges with its key product Apoquel and has new approvals in the pipeline to drive growth [13]. - Zoetis has increased its dividends by about 500% over the past decade, although its yield is 1.4% [14].

Group 1: Market Overview - Many investors are withdrawing from the stock market, but long-term investors recognize the importance of holding through volatility [1] - It remains a favorable time to invest in companies with strong underlying businesses and attractive long-term prospects, particularly dividend payers [1] Group 2: Medtronic - Medtronic is a leader in medical devices and may be affected by tariffs imposed by the current administration, particularly due to its significant revenue from the U.S. and manufacturing in Mexico and China [3][4] - Despite near-term uncertainties, Medtronic is considered a solid long-term investment due to its historical resilience in challenging economic conditions [4] - The company operates in a defensive industry, which helps it maintain steady financial results even during economic downturns [5] - Medtronic has consistent revenue and earnings growth, with significant opportunities in diabetes care and robotic-assisted surgery [7] - The company has a strong dividend track record, having increased payouts for 47 consecutive years, with a forward yield of 3.4% [8] Group 3: Merck - Merck has faced challenges in the past year due to potential competition for its cancer drug Keytruda and an upcoming patent cliff [9] - Despite these challenges, Merck's long-term prospects remain strong, as pharmaceutical companies often recover by developing new and improved medicines [10] - Merck is working on a subcutaneous formulation of Keytruda and has a deep pipeline with several dozen programs in development [10] - The company is expanding into the weight loss market and bispecific antibodies, which could enhance its treatment offerings [11] - Merck has a solid dividend program, having increased payouts by 80% over the past 10 years, with a current forward yield of 3.4% [12]

Core Insights - High-quality dividend stocks have historically outperformed non-payers, with an annualized return of 9.17% compared to 4.27% over the past 50 years [3] - The current market conditions, including a correction in major indices, make dividend stocks an attractive investment option [4] Group 1: Annaly Capital Management - Annaly Capital Management offers a yield of 13.79%, averaging around 10% over the last two decades, and has declared approximately $27 billion in dividends since its IPO in 1997 [5] - The company is sensitive to interest rate changes, with recent increases in the federal funds rate impacting its net interest margin and book value [6] - The Federal Reserve's current rate-easing cycle may benefit Annaly, allowing it to adjust its asset portfolio for better profitability [7] - Annaly's portfolio primarily consists of agency securities, which provide a safety net and allow for leverage to enhance profitability [8] - With improving yield-curve conditions and historical performance during declining interest rates, Annaly's financial metrics are expected to improve [9] Group 2: Realty Income - Realty Income has a yield of 5.56% and has increased its dividend for 110 consecutive quarters, positioning it well for long-term growth despite recession concerns [11] - The company's portfolio includes 15,621 commercial real estate properties, with 91% being resilient to economic downturns [12] - Realty Income's lessees are primarily brand-name businesses, ensuring consistent traffic and rental income even during economic challenges [12] - The company has a low percentage of lessees failing to pay rent, and its funds from operations are predictable [13] - Realty Income's shares are currently trading at a 22% discount to their five-year average cash flow multiple, indicating potential value [14] Group 3: Alliance Resource Partners - Alliance Resource Partners offers a yield of 10.26%, which has been sustainable despite the industry's challenges [15] - The company has successfully locked in volume and price commitments, ensuring consistent cash flow [17] - Alliance Resource has maintained a conservative approach to production expansion, resulting in a low net debt of $221.4 million [18] - The diversification into oil and natural gas royalties allows the company to benefit from price increases in these commodities [19] - The stock is valued at approximately 8.5 times forward-year earnings, presenting a solid investment opportunity [19]

Group 1: Lockheed Martin - Lockheed Martin has a record backlog of $176 billion, representing 2.4 years of sales based on 2025 guidance [4] - The company has a book-to-bill ratio of 1.2 times in 2024, indicating strong order momentum across all business areas [5] - Management expects mid-single-digit sales growth in 2025, with earnings per share guidance of $27-$27.30, comfortably covering the dividend per share of $13.20 [5] - Lockheed Martin's customers are primarily governments, ensuring reliable demand even during economic slowdowns [8] Group 2: Air Products & Chemicals - Air Products has increased its dividend for over 43 consecutive years, with a forward dividend yield of 2.4% [9][11] - The company has a strong infrastructure, including 1,800 miles of industrial gas pipeline and over 750 production facilities, creating high barriers to entry [10] - Air Products has achieved an approximately 8% compound annual growth rate in dividends from 2014 to 2025, with a payout ratio averaging 61% over the past five years [11] - The stock is currently trading at 17 times trailing earnings, below its historic P/E of 27, making it an attractive option for passive income [12] Group 3: FedEx - FedEx reported adjusted revenue of $22.2 billion, a 2.3% increase year-over-year, but has faced challenges with a poor near-term outlook [13] - The company has lowered its full-year guidance, projecting adjusted earnings per share of $18 to $18.60, which is below previous forecasts [14] - Despite near-term challenges, FedEx offers a dividend yield of 2.3%, comparable to well-known dividend stocks like Procter & Gamble and McDonald's [17] - The dividend payout of $5.52 per share is less than a third of its earnings guidance, indicating a safe payout ratio [18] - FedEx is considered a value stock for long-term investors with a three to five-year investment horizon [19]